Hospital-acquired Infection Control Market to Swell with an Absolute Dollar Opportunity of over US$ 12.7 billion in Next 10 Years, Reveals Future Market Insights DUBAI, United Arab Emirates, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The Hospital-Acquired Infection Control Market revenues were estimated at US$ 6.1 Bn in 2022 and is anticipated to grow at a CAGR of 7%...

Fedora Pharmaceuticals Demonstrates that FPI-1465 Increases Activity of Certain Antibiotics against Drug-Resistant Bacteria EDMONTON, Alberta, Sept. 12, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. and its collaborators presented results of preclinical studies demonstrating that FPI-1465 increases the activity of...